Vertex Pharmaceuticals
VRTX
VRTX
1,535 hedge funds and large institutions have $107B invested in Vertex Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 119 funds opening new positions, 627 increasing their positions, 574 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $110B → $107B (-$2.38B)
1.41% less ownership
Funds ownership: 91.01% → 89.59% (-1.4%)
12% less funds holding in top 10
Funds holding in top 10: 33 → 29 (-4)
Holders
1,535
Holding in Top 10
29
Calls
$881M
Puts
$721M
Top Buyers
| 1 | +$710M | |
| 2 | +$396M | |
| 3 | +$328M | |
| 4 |
BlackRock
New York
|
+$221M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$215M |
Top Sellers
| 1 | -$338M | |
| 2 | -$327M | |
| 3 | -$253M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$206M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$181M |